Overview

Exploratory Study on the Efficacy and Safety of Semaglutide for Idiopathic Intracranial Hypertension Treatment

Status:
NOT_YET_RECRUITING
Trial end date:
2025-01-01
Target enrollment:
Participant gender:
Summary
This study aims to investigate the safety and efficacy of semaglutide in patients with Idiopathic intracranial hypertension.
Phase:
PHASE3
Details
Lead Sponsor:
Capital Medical University
Treatments:
Caloric Restriction
semaglutide